Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 107.51%90.13K | -4,190.65%-1.92M | 80.39%-169.3K | -81.29%-2.04M | -31.50%70.45K | -1,699.36%-1.2M | 92.72%-44.76K | -58.18%-863.24K | 44.18%-1.12M | 117.80%102.86K |
| Net income from continuing operations | 13.10%-699.42K | -186.62%-1.98M | -1.89%-419.99K | -39.35%-3.66M | -37.03%-1.76M | -133.73%-804.88K | -56.73%-692.13K | 26.76%-412.19K | -3.99%-2.63M | -59.04%-1.28M |
| Operating gains losses | ---- | ---- | ---- | 142.24%20.47K | ---- | ---- | ---- | ---- | ---48.45K | ---- |
| Depreciation and amortization | 1.00%17.31K | 13.48%19.4K | -6.39%16K | 1.42%68.88K | -16.39%17.56K | 9.61%17.14K | 9.15%17.09K | 9.43%17.09K | 8.74%67.91K | 34.50%21K |
| Asset impairment expenditure | ---- | ---- | ---- | --691.12K | --100K | --0 | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | --64.18K | --501.11K | --14.69K | 1,711.88%799.46K | 79,945,600.00%799.46K | --0 | --0 | --0 | -87.53%44.12K | -100.00%-1 |
| Other non cashItems | 228.06%147.42K | 3,792.67%141.89K | 3,360.35%136.41K | 441.57%221.24K | 556.62%168.71K | 809.64%44.94K | -24.91%3.65K | -26.50%3.94K | 81.87%40.85K | 387.46%25.69K |
| Change In working capital | 222.54%560.65K | -1,787.31%-599.1K | 117.71%83.61K | -112.42%-174.08K | -48.05%720.01K | -280.28%-457.51K | 117.56%35.51K | -1,211.29%-472.08K | 1,732.69%1.4M | 1,720.00%1.39M |
| -Change in receivables | 92.02%-21.06K | -492.30%-68.03K | 684.27%146.44K | 63.36%33.61K | 984.42%261.64K | -3,357.88%-264.04K | 347.45%17.34K | -71.18%18.67K | 128.12%20.57K | -38.70%-29.58K |
| -Change in prepaid assets | -74.31%26.59K | -94.25%6.21K | 99.62%-1.14K | -109.82%-26.3K | -42.10%59.39K | -39.29%103.47K | -21.16%107.89K | -109.06%-297.04K | 203.81%267.76K | 147.04%102.57K |
| -Change in payables and accrued expense | 282.91%543.13K | -512.19%-549.27K | 58.86%-79.69K | -141.60%-340.52K | -76.45%239.84K | -426.36%-296.93K | 72.97%-89.72K | -569.19%-193.71K | 151.55%818.52K | 222.72%1.02M |
| -Change in other current liabilities | --12K | --12K | --18K | -46.00%159.13K | --159.13K | --0 | ---- | ---- | --294.72K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 107.51%90.13K | -4,190.65%-1.92M | 80.39%-169.3K | -81.29%-2.04M | -31.50%70.45K | -1,699.36%-1.2M | 92.72%-44.76K | -58.18%-863.24K | 44.18%-1.12M | 117.80%102.86K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 20.73%-1.68M | -106.46%-310.21K | 50.68%-331.68K | 0.71%-2.11M | 259.12%835.61K | -434.44%-2.12M | 38.93%-150.25K | 29.59%-672.47K | 50.41%-2.12M | 46.78%-525.16K |
| Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---141.77K | --0 | ---- |
| Net other investing changes | -171.08%-1.68M | -6.23%-310.21K | 37.50%-331.68K | 0.71%-2.11M | -26.65%-665.13K | -56.29%-620.25K | -18.68%-292.02K | 44.43%-530.7K | 50.06%-2.12M | 45.11%-525.16K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 20.73%-1.68M | -106.46%-310.21K | 50.68%-331.68K | 0.71%-2.11M | 259.12%835.61K | -434.44%-2.12M | 38.93%-150.25K | 29.59%-672.47K | 50.41%-2.12M | 46.78%-525.16K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.53%-19.49K | 29,264.28%5.45M | -101.10%-19.49K | 486.50%5.14M | -220.63%-320.16K | 1,040.94%3.71M | -109.14%-18.69K | 2,083.62%1.77M | -85.44%875.97K | -92.68%265.41K |
| Net issuance payments of debt | -100.57%-19.49K | -4.27%-19.49K | -4.28%-19.49K | 4,768.28%3.35M | -216.84%-46.24K | 17,398.62%3.44M | -2.23%-18.69K | 2.08%-18.69K | -4.65%-71.83K | 15.93%-14.59K |
| Net common stock issuance | --0 | --5.47M | --0 | --0 | -1,958.20%-2.06M | -26.74%272.67K | --0 | --1.79M | -91.30%495K | -103.08%-100K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---2.06M | ---- | ---- | ---- | -81.42%72.8K | --0 |
| Net other financing activities | ---- | ---- | ---- | 369.55%1.78M | ---- | ---- | ---- | ---- | --380K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.53%-19.49K | 29,264.28%5.45M | -101.10%-19.49K | 486.50%5.14M | -220.63%-320.16K | 1,040.94%3.71M | -109.14%-18.69K | 2,083.62%1.77M | -85.44%875.97K | -92.68%265.41K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,162.97%3.84M | 58.33%617.75K | 652.46%1.14M | -93.93%151.52K | 96.70%548.06K | -59.57%169.52K | -63.52%390.17K | -93.93%151.52K | -9.51%2.5M | -40.63%278.63K |
| Current changes in cash | -514.86%-1.61M | 1,606.86%3.22M | -325.18%-520.46K | 141.82%991.59K | 473.44%585.9K | 380.46%388.26K | 67.42%-213.7K | 116.28%231.13K | -745.26%-2.37M | -107.62%-156.89K |
| Effect of exchange rate changes | 46.27%-5.22K | 76.31%-1.65K | -125.42%-1.91K | -110.99%-2.98K | -79.32%6.16K | -343.90%-9.72K | -220.92%-6.95K | 221.49%7.52K | 48.36%27.15K | 188.44%29.79K |
| End cash Position | 305.12%2.22M | 2,162.97%3.84M | 58.33%617.75K | 652.46%1.14M | 652.46%1.14M | 96.70%548.06K | -59.57%169.52K | -63.52%390.17K | -93.93%151.52K | -93.93%151.52K |
| Free cash from | 107.51%90.13K | -2,079.70%-1.92M | 83.15%-169.3K | -81.29%-2.04M | -31.50%70.45K | -1,699.36%-1.2M | 115.79%97.01K | -84.15%-1.01M | 45.00%-1.12M | 116.92%102.86K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.